Cary Street Partners Investment Advisory LLC Precigen, Inc. Transaction History
Cary Street Partners Investment Advisory LLC
- $2.63 Billion
- Q3 2024
A detailed history of Cary Street Partners Investment Advisory LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 87,593 shares of PGEN stock, worth $69,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,593
Previous 87,593
-0.0%
Holding current value
$69,198
Previous $138,000
39.86%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding PGEN
# of Institutions
143Shares Held
159MCall Options Held
232KPut Options Held
69K-
Third Security, LLC83.5MShares$65.9 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$14.2 Million0.92% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$8.58 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$8.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$6.58 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $164M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...